Maria E. Ourailidou

538 total citations
10 papers, 446 citations indexed

About

Maria E. Ourailidou is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Maria E. Ourailidou has authored 10 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Maria E. Ourailidou's work include Histone Deacetylase Inhibitors Research (6 papers), Click Chemistry and Applications (4 papers) and Peptidase Inhibition and Analysis (3 papers). Maria E. Ourailidou is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Click Chemistry and Applications (4 papers) and Peptidase Inhibition and Analysis (3 papers). Maria E. Ourailidou collaborates with scholars based in Netherlands, Italy and Germany. Maria E. Ourailidou's co-authors include Frank J. Dekker, Wiktor Szymański, Ben L. Feringa, Willem A. Velema, Niek G.J. Leus, Hidde J. Haisma, Rainer Bischoff, Thea van den Bosch, Petra E. van der Wouden and Loes Kistemaker and has published in prestigious journals such as Scientific Reports, Chemistry - A European Journal and Biochemical Pharmacology.

In The Last Decade

Maria E. Ourailidou

10 papers receiving 443 citations

Peers

Maria E. Ourailidou

CMN

ONCOL

Simon J. Middendorp Switzerland

C. Pichlo Germany

Toshihiko Tashima Japan

Mari Haramoto Japan

Ariane E. Marolewski United States

Erin D. Anderson United States

E. Allen Sickmier United States

Claudia Hinze United Kingdom

Ali Munaim Yousif Italy

Agata A. Bielska United States

Simon J. Middendorp Switzerland

Maria E. Ourailidou

216 ×0.8

70 ×0.5

126 ×1.0

171 ×2.1

CMN

36 ×0.5

ONCOL

Citations per year, relative to Maria E. Ourailidou Maria E. Ourailidou (= 1×) peers Simon J. Middendorp

Countries citing papers authored by Maria E. Ourailidou

Since Specialization

Citations

This map shows the geographic impact of Maria E. Ourailidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria E. Ourailidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria E. Ourailidou more than expected).

Fields of papers citing papers by Maria E. Ourailidou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria E. Ourailidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria E. Ourailidou. The network helps show where Maria E. Ourailidou may publish in the future.

Co-authorship network of co-authors of Maria E. Ourailidou

This figure shows the co-authorship network connecting the top 25 collaborators of Maria E. Ourailidou. A scholar is included among the top collaborators of Maria E. Ourailidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria E. Ourailidou. Maria E. Ourailidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Hoorens, Mark W. H., Maria E. Ourailidou, Petra E. van der Wouden, et al.. (2019). Light-controlled inhibition of BRAFV600E kinase. European Journal of Medicinal Chemistry. 179. 133–146. 32 indexed citations

Leus, Niek G.J., Thea van den Bosch, Petra E. van der Wouden, et al.. (2017). HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice. Scientific Reports. 7(1). 45047–45047. 64 indexed citations

Leus, Niek G.J., Petra E. van der Wouden, Thea van den Bosch, et al.. (2016). HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Biochemical Pharmacology. 108. 58–74. 105 indexed citations

Ourailidou, Maria E., et al.. (2016). Towards the development of activity-based probes for detection of lysine-specific demethylase-1 activity. Bioorganic & Medicinal Chemistry. 25(3). 847–856. 8 indexed citations

Ourailidou, Maria E., et al.. (2016). Chemical epigenetics to assess the role of HDAC1–3 inhibition in macrophage pro-inflammatory gene expression. MedChemComm. 7(11). 2184–2190. 6 indexed citations

Bosch, Thea van den, Alexander P. Boichenko, Niek G.J. Leus, et al.. (2015). The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases. Biochemical Pharmacology. 102. 130–140. 47 indexed citations

Szymański, Wiktor, Maria E. Ourailidou, Willem A. Velema, Frank J. Dekker, & Ben L. Feringa. (2015). Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy. Chemistry - A European Journal. 21(46). 16517–16524. 114 indexed citations

Ourailidou, Maria E., et al.. (2015). Metabolic alkene labeling and in vitro detection of histone acylation via the aqueous oxidative Heck reaction. Organic & Biomolecular Chemistry. 13(12). 3648–3653. 21 indexed citations

Ourailidou, Maria E., Martijn R. H. Zwinderman, & Frank J. Dekker. (2015). Bioorthogonal metabolic labelling with acyl-CoA reporters: targeting protein acylation. MedChemComm. 7(3). 399–408. 8 indexed citations

10.

Ourailidou, Maria E., Jan‐Ytzen van der Meer, Bert‐Jan Baas, et al.. (2013). Aqueous Oxidative Heck Reaction as a Protein‐Labeling Strategy. ChemBioChem. 15(2). 209–212. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact